Our recent transaction with Medirom Healthcare Technologies, Inc. (NASDAQ: MRM). Link to press release: https://lnkd.in/dBPcsGf6
About us
ThinkEquity is a boutique investment bank created by experienced professionals that have worked together for over a decade, collectively financing over $50 billion of public and private capital raises, restructurings, and mergers and acquisitions. The ThinkEquity model is built around the clients’ needs, no matter how complicated or around the clock attention required, and to identify solutions that help them to create value for their investors.
- Website
-
http://www.think-equity.com
External link for ThinkEquity LLC
- Industry
- Financial Services
- Company size
- 51-200 employees
- Headquarters
- New York, New York
- Type
- Privately Held
- Founded
- 1987
Locations
-
Primary
Get directions
17 State St
New York, New York 10004, US
Employees at ThinkEquity LLC
Updates
-
Our recent transaction with Venu Holding Corp. (NYSE American: VENU). Link to press release: https://lnkd.in/eC9_K9rQ
-
-
ThinkEquity LLC reposted this
You will no longer hear shouting and yelling of traders, but whirring and buzzing of computers. Still, the visit on NYSE floor is an exceptional experience. Even more so at times when the stock market hit new records after a post-election surge. Thanks Samat Umirzakov and ThinkEquity LLC for this valuable opportunity.
-
-
Our recent transaction with Sidus Space, Inc. (NASDAQ: SIDU). Link to press release: https://lnkd.in/gCt2xFdU
-
-
Our recent transaction with KWESST Micro Systems, Inc. (NASDAQ: KWE). Link to press release: https://lnkd.in/ebkDUzhv
-
-
Our recent transaction with GreenPower Motor Company, Inc. (NASDAQ: GP). Link to press release: https://lnkd.in/eRuD9jKz
-
-
Our recent transaction with High Roller Technologies, Inc. (NYSE American: ROLR). Link to press release: https://lnkd.in/eH-NZPBD
-
-
We’re #hiring a new Investment Banking- Equity Capital Markets in New York, New York. Apply today or share this post with your network.
-
Our recent transaction with BriaCell Therapeutics (NASDAQ: BCTX). Link to press release: https://lnkd.in/eXDBx7wt
-
-
Lantern Pharma, Inc. (NASDAQ: LTRN) invites you to an investor dinner and presentation. Join us for an engaging presentation by Panna Sharma, CEO, who will discuss how Lantern is harnessing A.I., machine learning, and genomics to transform the cost, pace, and timeline of oncology drug discovery and development. Please RSVP to corporateaccess@think-equity.com
This content isn’t available here
Access this content and more in the LinkedIn app